Novel Vaccine Strategy Produces Rapid and Long-Term Protection Against Chikungunya Virus
Thursday, March 31, 2016 - 14:30
in Health & Medicine
Now, new research from The Wistar Institute has demonstrated how a novel vaccine strategy that boosts the immune system by rapidly producing antibodies against CHIKV, combined with a traditional DNA-based vaccine approach, can provide both short term and long term protection against the virus. Study results are published in the Journal of Infectious Diseases.